Changes in Wnt and TGF-β Signaling Mediate the Development of Regorafenib Resistance in Hepatocellular Carcinoma Cell Line HuH7

Hepatocellular carcinoma (HCC) is an aggressive, chemo resistant neoplasm with poor prognosis and limited treatment options. Exploring activated pathways upon drug treatment can be used to discover more effective anticancer agents to overcome therapy resistance and enhance therapeutic outcomes for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Karabicici, Mustafa, Azbazdar, Yagmur, Ozhan, Gunes, Senturk, Serif, Firtina Karagonlar, Zeynep, Erdal, Esra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386122/
https://www.ncbi.nlm.nih.gov/pubmed/34458250
http://dx.doi.org/10.3389/fcell.2021.639779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386122/
https://www.ncbi.nlm.nih.gov/pubmed/34458250
http://dx.doi.org/10.3389/fcell.2021.639779

Ejemplares similares